Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||
| Net Income | -54,320 | -2,650 | 2,950 |
| Other Operating Activity | -20,730 | 22,350 | 12,310 |
| Operating Cash Flow | $-75,050 | $19,700 | $15,260 |
| Cash Flows From Investing Activities | |||
| Other Investing Activity | 204,520 | 185,650 | -104,480 |
| Investing Cash Flow | $204,520 | $185,650 | $-104,480 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 180,580 | 161,980 | 162,760 |
| Financing Cash Flow | $180,580 | $161,980 | $162,760 |
| Exchange Rate Effect | 6,600 | 3,650 | 6 |
| Beginning Cash Position | 102,230 | 102,230 | 102,230 |
| End Cash Position | 418,890 | 473,230 | 175,780 |
| Net Cash Flow | $316,660 | $371,000 | $73,540 |
| Free Cash Flow | |||
| Operating Cash Flow | -75,050 | 19,700 | 15,260 |
| Free Cash Flow | -75,050 | 19,700 | 15,260 |